Astera Labs, Inc. $ALAB Shares Bought by Tobam

Tobam raised its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 115.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,363 shares of the company’s stock after buying an additional 6,613 shares during the period. Tobam’s holdings in Astera Labs were worth $2,057,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also modified their holdings of ALAB. Assetmark Inc. raised its holdings in shares of Astera Labs by 374.1% in the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after buying an additional 101 shares during the period. Smartleaf Asset Management LLC boosted its holdings in Astera Labs by 422.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after acquiring an additional 152 shares during the period. Hilltop National Bank boosted its holdings in Astera Labs by 100.0% during the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after acquiring an additional 100 shares during the period. Aventura Private Wealth LLC acquired a new position in Astera Labs in the 4th quarter valued at about $33,000. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA acquired a new position in Astera Labs in the 4th quarter valued at about $33,000. 60.47% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts have recently issued reports on the stock. Morgan Stanley increased their price target on shares of Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. Northland Securities cut shares of Astera Labs from an “outperform” rating to a “market perform” rating in a report on Tuesday, May 26th. Jefferies Financial Group reiterated a “buy” rating and set a $270.00 target price on shares of Astera Labs in a report on Wednesday, May 6th. Royal Bank Of Canada raised their price target on shares of Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a research report on Wednesday, May 6th. Finally, Evercore reaffirmed an “outperform” rating and set a $297.00 price objective on shares of Astera Labs in a research report on Tuesday, May 19th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. According to MarketBeat.com, Astera Labs currently has a consensus rating of “Moderate Buy” and an average target price of $233.75.

Astera Labs Price Performance

NASDAQ ALAB opened at $417.07 on Friday. Astera Labs, Inc. has a 1 year low of $84.78 and a 1 year high of $421.20. The company has a market capitalization of $71.49 billion, a PE ratio of 281.80, a P/E/G ratio of 5.52 and a beta of 3.95. The company has a fifty day moving average of $264.43 and a two-hundred day moving average of $187.34.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. During the same quarter last year, the company posted $0.33 earnings per share. The business’s quarterly revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, research analysts expect that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Insider Transactions at Astera Labs

In other Astera Labs news, General Counsel Philip Mazzara sold 796 shares of the business’s stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $291.03, for a total value of $231,659.88. Following the completion of the sale, the general counsel owned 103,343 shares in the company, valued at approximately $30,075,913.29. The trade was a 0.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the stock in a transaction that occurred on Wednesday, June 3rd. The shares were sold at an average price of $364.35, for a total value of $1,277,046.75. Following the completion of the sale, the director directly owned 60,134 shares of the company’s stock, valued at $21,909,822.90. The trade was a 5.51% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 2,161,256 shares of company stock worth $459,844,296. Insiders own 10.40% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.